Code Kenneth Reay

Chief Science Officer, DirectorBIOLARGO, INC. (BLGO) · full profile →Form 4 · filed Oct 3, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 30, 2023Grant(A)19K$0.17$3K25.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-027572) within minutes of acceptance. Every field above traces to the original document. Verify it directly: